Author:
de Souza Isabela Pilar Moraes Alves,Ramos João Victor Santos Pereira,da Silveira Anderson Donelli,Stein Ricardo,Ribeiro Rebeca Sadigursky,Pazelli Alexandre Meira,de Oliveira Queila Borges,Darzé Eduardo Sahade,Ritt Luiz Eduardo Fonteles
Abstract
Purpose:
The objective of this study was to evaluate the independent and added value of a cardiopulmonary exercise test (CPX) to New York Heart Association (NYHA) functional analysis in patients with heart failure (HF) and ejection fraction (EF) <50%.
Methods:
Patients (n = 613) with HF and EF < 50% underwent CPX and were followed for 28 ± 17 mo with respect to primary outcomes (death or heart transplantation).
Results:
Mean patient age was 57 ± 12 yr and 64% were male. Most patients were classified as NYHA class II (41%). The composite rate of primary outcomes was 12%; death occurred in 9% and heart transplant in 4%. Independent predictors of primary outcomes were: EF (HR = 0.95: 95% CI, 0.92-0.98; P = .001) and NYHA (HR = 2.06: 95% CI, 1.54-2.75; P < .0001). When added to the model, peak oxygen uptake (V˙O
2peak) was an independent predictor (HR = 0.90: 95% CI, 0.84-0.96; P = .001), as was the percentage of predicted V˙O
2peak (HR = 0.03: 95% CI, 0.007-0.147; P < .001), minute ventilation/carbon dioxide production slope (HR = 1.02: 95% CI, 1.01-1.04; P = .012), and CPX score (HR = 1.16: 95% CI, 1.06-1.27; P = .001).
Conclusions:
CPX variables were independent predictors of HJ prognosis, even when controlled by NYHA functional class. Despite being independent predictors, the value added to NYHA classification was modest and lacked statistical significance.
Patients with heart failure (HF) underwent cardiopulmonary exercise testing (CPX) and were followed with respect to primary outcomes (death or heart transplantation). Independent predictors of primary outcomes were: ejection fraction and New York Heart Association (NYHA). The CPX variables were independent predictors of HF prognosis, even when controlled by NYHA. However, the value added to NYHA classification was modest.
Publisher
Ovid Technologies (Wolters Kluwer Health)